AliveCor

AliveCor introduces the world's first AI that can detect heart attack on a reduced leadset in monumental dual clearance by the FDA. Today, AliveCor launched the all-new, AI-powered Kardia 12L ECG System, which is FDA-cleared to detect 35 cardiac conditions including serious conditions like acute myocardial infarction (MI) and the most common types of cardiac ischemia. The 12-lead ECG has been the standard of cardiac care since 1954, but its availability has been limited. Until now. Small enough to fit in a pocket, Kardia 12L boasts advanced AI algorithms that are substantially equivalent to the current state-of-the-art ECG analysis solutions. Learn how Kardia 12L can assist physicians in rapid disease detection, enhance patient experience, and expand access to accurate heart data faster and more conveniently than ever before.